Additionally, we investigated the impact of CD38 on IgD+ CD24-on PD risk using the IVW method, which suggested a significant correlation (OR = 1.14, 95% CI = 1.06–1.23, p = 0.001, PFDR = 0.152). Here, CD38 is linked to Parkinson disease.